[Structured therapeutic interruption in patients infected with HIV-1 experiencing a block in their antiretroviral treatment: preliminary results].
D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count; D003586:Cytomegalovirus Infections / Q000209:etiology; D004334:Drug Administration Schedule; D024882:Drug Resistance, Viral; D005500:Follow-Up Studies; D005838:Genotype; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D015497:HIV-1 / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011536:Prurigo / Q000209:etiology; D016896:Treatment Outcome; D019562:Viral Load; D014766:Viremia / Q000209:etiology
Interruption thérapeutique programmée chez des patients infectés par le VIH-1 en échec d'un traitement antirétroviral: résultats préliminaires.